Raymond James Financial Inc. acquired a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund acquired 33,923 shares of the company’s stock, valued at approximately $155,000.
Several other institutional investors and hedge funds also recently modified their holdings of the stock. Jane Street Group LLC boosted its stake in shares of Aveanna Healthcare by 127.4% in the third quarter. Jane Street Group LLC now owns 118,803 shares of the company’s stock valued at $618,000 after purchasing an additional 66,561 shares during the period. Geode Capital Management LLC lifted its holdings in Aveanna Healthcare by 4.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,401,016 shares of the company’s stock worth $7,287,000 after buying an additional 63,190 shares in the last quarter. JPMorgan Chase & Co. boosted its position in Aveanna Healthcare by 266.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 85,714 shares of the company’s stock valued at $446,000 after buying an additional 62,319 shares during the last quarter. Barclays PLC grew its stake in shares of Aveanna Healthcare by 80.1% during the third quarter. Barclays PLC now owns 122,689 shares of the company’s stock valued at $637,000 after acquiring an additional 54,557 shares in the last quarter. Finally, Seizert Capital Partners LLC purchased a new stake in shares of Aveanna Healthcare during the fourth quarter worth about $166,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Aveanna Healthcare Stock Performance
Shares of Aveanna Healthcare stock opened at $4.49 on Friday. Aveanna Healthcare Holdings Inc. has a 1 year low of $2.11 and a 1 year high of $6.19. The firm’s 50-day simple moving average is $4.79 and its 200-day simple moving average is $4.93. The firm has a market cap of $875.97 million, a PE ratio of -13.21 and a beta of 1.99.
Insider Buying and Selling at Aveanna Healthcare
Wall Street Analysts Forecast Growth
AVAH has been the subject of a number of analyst reports. Truist Financial reduced their price target on Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating for the company in a report on Friday. UBS Group increased their target price on Aveanna Healthcare from $3.20 to $4.50 and gave the company a “sell” rating in a research note on Friday, March 14th.
View Our Latest Stock Report on AVAH
Aveanna Healthcare Profile
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Read More
- Five stocks we like better than Aveanna Healthcare
- Dividend Capture Strategy: What You Need to Know
- Robinhood Strategies Could Be a Game-Changer for Young Investors
- Differences Between Momentum Investing and Long Term Investing
- Are These 3 Retail Stocks Oversold or Really in Trouble?
- 3 REITs to Buy and Hold for the Long Term
- IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead
Want to see what other hedge funds are holding AVAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Free Report).
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.